Since 1990, helping busy clinicians master the science and art of caring for people with HIV disease.

PRN News

CROI 2013: Promising interferon-free regimens in HCV mono-infection

CROI 2013: Inflammation & coronary heart disease are more aggressive in HIV

CROI 2013: Random anal biopsies improve detection of high-grade precancerous lesions

CROI 2013: Adding telaprevir improves response & shortens treatment of acute HCV in HIV-positive MSM

CROI 2013: Triple therapy for HCV-HIV coinfection with 2nd generation HCV protease inhibitors

CROI 2013: Must NRTIs be included in new regimen after failing a PI-containing regimen?

CROI 2013: Is heart failure a looming problem in HIV?

CROI 2013: Obesity in HIV

CROI 2013: A closer look at HIV-positives lost to follow-up

CROI 2013: Drug-resistant HIV transmission is increasing in NYC immigrant populations

CROI 2013: Major HIV drug resistance mutations in ARV-naïve adolescents and young adults

CROI 2013: More evidence for higher risk of cardiovascular disease among HIV-positives

CROI 2013: Triple therapy for HCV co-infected patients who failed dual therapy

CROI 2013: Long-acting integrase inhibitor prevents rectal transmission of SHIV in macaques

CROI 2013: Monthly tenofovir intravaginal ring prevents SHIV infection in female macaques

CROI 2013: Pre-exposure prophylaxis fails to protect women from HIV in African study

Ongoing research on licensed ARVs presented at AIDS 2012

More starting treatment, with more options for ART in the pipeline

Expanding HIV testing and treatment globally

HIV vaccine update AIDS 2012 in Washington DC

US trade policies impact global drug pricing

More about: Towards an HIV cure

Towards an HIV Cure: Workshop Summary

Pre-IAS meeting spotlights MSM and transgender health issues

Long-acting, intramuscular formulation of ripilvirine for PrEP

Improved rectal microbicide for PrEP is safe and well-tolerated

No sign of tenofovir-induced resistance when PrEP with vaginal gel fails

Intracellular drug levels and PrEP dosing strategies

Plasma drug levels as markers of adherence in PrEP

Short course antiretroviral therapy in primary HIV infection: the SPARTAC results

Elvitegravir Noninferior to Raltegravir

New point-of-care test for cryptococcal antigen may save thousands of lives.

PrEP: Adherence Matters

More studies show success of pre-exposure prophylaxis in preventing HIV transmission

Session dedicated to adolescent health at IAS Conference, Rome

The IAS calls for therapeutic and treatment strategies to cure HIV/AIDS

27% reduction in HIV disease progression among HSV-2 coinfected subjects treated with acyclovir

Treatment as Prevention: 96% reduction in HIV transmission among HIV-serodiscordant partnerships

IAS 2011: Disappointing results from Raltegravir intensification study for immune failure.

IAS 2011: Comorbidities and non-AIDS events

IAS 2011: Antiretroviral drugs and risk of cardiovascular disease

IAS 2011: Interpreting the Data: Selection Bias?

IAS 2011: Cardiovascular Risk Management: A Multidisciplinary Effort

IAS 2011: Final Data on ARIES Study Released

IAS 2011: Initial Results Released on Simplified NRTI-Sparing Strategy: RAL + DRV/r

IAS 2011: Treatment = Prevention

NanoART for Improved Drug Delivery

Low-Dose Ritonavir Does Not Affect PK of Investigational HCV Protease Inhibitor

Study Shows Rectal-Specific Formulation of Tenofovir Gel is Needed

Infusion of Genetically-Modified HIV-Resistant CD4 Cells Show Potential Benefit

Post-Exposure Topical Vaginal Gel Containing Raltegravir Protects Macaques from SHIV Infection

Intermittent Truvada Protects Against Rectal Transmission of Emtricitabine-Resistant SHIV

UNITED KINGDOM: AIDS ‘Fatigue’ May Cause Lack of Funds, Former UNAIDS Head Says

UNITED STATES: More, but Not Enough, Americans Get AIDS Tests

GLOBAL: Complacency Fuels New AIDS Surge in West: UN

GLOBAL: UNICEF Says HIV-Free Generation Is Achievable

UNITED STATES: Merck’s HIV Drug Isentress Fails Once-a-Day Study

UNITED STATES: Targeted HPV Vaccination of MSM in the USA: A Cost-Effectiveness Modeling Analysis

AUSTRALIA: Experts Pushing for Rapid HIV Testing

EUROPE: UNAIDS Chief: Spread of HIV in E. Europe Is Scary

FLORIDA: Florida’s AIDS Medication Program Feeling Strained

UNITED STATES: OraSure HIV Test Inches Closer to FDA Approval

UNITED STATES: HIV+ Women Need Annual Cervical Cytology: ACOG Guidelines

UNITED STATES: Delaying Treatment for HIV Can Become Costly

GLOBAL: Three Big Developments Make AIDS Outlook More Hopeful

SOUTH AFRICA: ‘Whoonga’ Drug: A New Twist in South Africa’s AIDS War

DISTRICT OF COLUMBIA: D.C. Officials Quiz Doctors about HIV/AIDS

UNITED STATES: Researchers Uncover Insulin Resistance Link

GLOBAL: Treating Prisoners While Jailed Could Stop Disease

GLOBAL: Truvada Cuts HIV Risk Significantly in San Francisco Study

NEW YORK: HIV/AIDS Agency Seeks Clients for Nutrition Program

UNITED STATES: Vertex Submits Application for Hepatitis C Drug

GLOBAL: UN Sees Global AIDS Epidemic Starting to Turn

Massachusetts Inmates Sue over New Rules on HIV Medication: HIV Patients Now Must Wait in Line

UNITED STATES: AIDS is ‘Forgotten Epidemic,’ Koop Says

SOUTH AFRICA: Hope for South Africa’s AIDS Fight

CHINA: China’s HIV/AIDS Policies Need to Be Fully Implemented at All Levels: Researcher

UNITED STATES: US Panel Positive on Merck Vaccine for Anal Cancer